Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TDH Capital
Beijing, Beijing, China
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
TDH Capital (Tianyuan Dicong Capital) is a premier healthcare-focused investment firm headquartered in Beijing, China. The firm specializes in venture capital and private equity investments across the life sciences spectrum, including biopharmaceuticals, medical technology, and healthcare services. TDH Capital is recognized for its deep domain expertise and a research-driven approach to identifying high-potential startups and growth-stage companies. Its notable portfolio includes industry leaders such as CanSino Biologics, RemeGen, and New Horizon Health. By providing strategic capital and operational support, TDH Capital plays a pivotal role in fostering innovation within the Chinese and global healthcare markets.
- Therapeutic areas
- ImmunologyCardiovascularInfectious DiseasesMetabolic DisordersOncology
- Modalities
- Small moleculeMonoclonal antibodyVaccineCell therapyGene therapyMedical Device
- Industry
- Investors
Beyond the preview
Go deeper on TDH Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TDH Capital.